Products
AgressTM
 |
bioFILM PA™ Products
The Centers for Diseases Control reports that 60% of all infectious diseases are caused by organisms in a biofilm state and biofilms are the predominant cause of chronic pulmonary infections in Cystic Fibrosis, Ventilator Associated Pneumonia and burn or wound infections. Biofilm infections are up to 4000 times more difficult to treat than conventional infections.
bioFILM PATM is the first in-vitro diagnostic tool designed to help physicians fight resistant biofilm diseases.
As easy to use as an MIC test, it’s the only test of its kind that provides Pseudomonas susceptibilities at serum breakpoint levels . Choosing the right antibiotics to treat infections requires an in-vitro susceptibility test that that closely approximates the in-vivo condition, and bioFILM PATM is the world’s first susceptibility test for organism in planktonic and biofilm states, testing the bacteria against single and combination antibiotics. bioFILM PATM provides improved susceptibility information not only for Cystic Fibrosis lung infections but also for pneumonia, burns, wounds and other chronic Pseudomonas infections.
Click to download the following bioFILM PA™ documents
- bioFILM PA™ FAQ (pdf)
- bioFILM PA™ Antimicrobial Susceptibility System Panel Layout (pdf)
- bioFILM PA™ Antimicrobial Susceptibility Flyer (pdf)
- bioFILM PA™ Product Insert
- bioFILM PA™ Flow Diagram
 |
Damian Sowa 780-448-0585 ext 225 or damian.sowa@innovotech.ca.